Urine: An under-studied source of biomarkers in multiple sclerosis?

Multiple Sclerosis and Related Disorders

Volumn 1, Issue 2, 2012, Pages 76-80

  Dobson, Ruth ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Biomarkers; Disease monitoring; Immunoglobulin; Multiple sclerosis; Neopterin; Urine

Indexed keywords

ALUMINUM; BETA 2 MICROGLOBULIN; BETA INTERFERON; BETA1A INTERFERON; BIOLOGICAL MARKER; CREATININE; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; IRON; MYELIN BASIC PROTEIN; MYELIN BASIC PROTEIN LIKE PROTEIN; NEOPTERIN; NITRATE; NITRIC OXIDE; NITRITE; PLACEBO; SILICON; STEROID; UNCLASSIFIED DRUG;

CLINICAL PRACTICE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN ANALYSIS; RELAPSE; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINARY EXCRETION;

EID: 84857790885     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2012.01.002     Document Type: Review

References (47)

1. G. Acar Nitric oxide as an activity marker in multiple sclerosis Journal of Neurology 250 5 2003 588 592 (Pubitemid 36613303)
2. A. Awad Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis Journal of Neuroimmunology 219 12 2010 1 7
3. F. Bagnato A one-year study on the pharmacodynamic profile of interferon-beta1a in MS Neurology 58 9 2002 1409 1411 (Pubitemid 34507172)
4. F. Bagnato Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology Suppl. 5 2003 S301 S304 24 Suppl. 5 2003 S301 S304 (Pubitemid 37493207)
5. J.S. Beckman Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proceedings of the National Academy of Sciences of the United States of America 87 4 1990 1620 1624
6. A.M. Bernard, A. Vyskocil, and R.R. Lauwerys Determination of beta 2-microglobulin in human urine and serum by latex immunoassay Clinical Chemistry 27 6 1981 832 837 (Pubitemid 11042759)
7. B. Bielekova, and R. Martin Development of biomarkers in multiple sclerosis Brain 127 Pt 7 2004 1463 1478 (Pubitemid 38899400)
8. O.W. Bjerrum, F.W. Bach, and I. Zeeberg Increased level of cerebrospinal fluid beta 2-microglobulin is related to neurologic impairment in multiple sclerosis Acta Neurologica Scandinavica 78 1 1988 72 75
9. L. Brundin Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies 6 5 1999 585 590 (Pubitemid 30028814)
10. P.B. Carrieri Cerebrospinal fluid beta-2-microglobulin in multiple sclerosis and AIDS dementia complex Neurological Research 14 3 1992 282 283
11. S.D. Cook Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients Neurology 57 6 2001 1080 1084 (Pubitemid 32880206)
12. Dobson, R, et al. Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis. Journal of Neuroimmunology, 2010a.
13. R. Dobson, S.M. Leary, A.J. Thompson, and G. Giovannoni Urinary free light chain excretion in primary progressive multiple sclerosis Multiple Sclerosis 16 2010 S188 S189
14. J. Egberts, and W. Soederhuizen Urine samples before dinner are preferable when studying changes in endogenous nitrate production under uncontrolled dietary conditions Clinica Chimica Acta; International Journal of Clinical Chemistry 254 2 1996 141 148 (Pubitemid 26325563)
15. C. Exley Elevated urinary excretion of aluminium and iron in multiple sclerosis Multiple Sclerosis 12 5 2006 533 540 (Pubitemid 46940625)
16. S. Fredrikson, H. Link, and P. Eneroth CSF neopterin as marker of disease activity in multiple sclerosis Acta Neurologica Scandinavica 75 5 1987 352 355 (Pubitemid 17086655)
17. D. Fuchs The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases Critical Reviews in Clinical Laboratory Sciences 29 34 1992 307 341 (Pubitemid 23011151)
18. G. Giovannoni Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis Multiple Sclerosis 4 1 1998 27 30 (Pubitemid 28077433)
19. G. Giovannoni, and E.J. Thompson Urinary markers of disease activity in multiple sclerosis Multiple Sclerosis 4 3 1998 247 253 (Pubitemid 28410060)
20. G. Giovannoni Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis Annals of Neurology 40 1 1996 128 129 (Pubitemid 26250155)
21. G. Giovannoni Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis Brain: A Journal of Neurology 120 Pt 1 1997 1 13 (Pubitemid 27081256)
22. G. Giovannoni Raised serum nitrate and nitrite levels in patients with multiple sclerosis Journal of Neurological Sciences 145 1 1997 77 81 (Pubitemid 27141582)
23. G. Giovannoni Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels Annals of Clinical Biochemistry 34 Pt 2 1997 193 198 (Pubitemid 27121044)
24. G. Giovannoni Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease Multiple Sclerosis 5 5 1999 335 341 (Pubitemid 29505048)
25. J.J. Graber, and S. Dhib-Jalbut Biomarkers of disease activity in multiple sclerosis Journal of the Neurological Sciences 305 12 2011 1 10
26. C. Huber Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma The Journal of Experimental Medicine 160 1 1984 310 316 (Pubitemid 14089799)
27. H. Khorami Increased urinary neopterin: creatinine ratio as a marker of activation of cell-mediated immunity and oxidative stress in the Iranian patients with multiple sclerosis Iranian Journal of Allergy, Asthma, and Immunology 2 3 2003 155 158
28. J.M. Langrehr Nitric oxidea new endogenous immunomodulator Transplantation 55 6 1993 1205 1212 (Pubitemid 23183225)
29. R.F. Lin Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study The Journal of Experimental Medicine 178 2 1993 643 648 (Pubitemid 23218213)
30. P. Mehta Increased free light chains in the urine from patients with multiple sclerosis Neurology 41 4 1991 540 544
31. R.P. Messner Beta 2-microglobulin: an old molecule assumes a new look The Journal of Laboratory and Clinical Medicine 104 2 1984 141 145 (Pubitemid 14055128)
32. A. Niederweiser, and S.W. Wetzel Automatic HPLC of pterins with or without column switching H. Wachter, H.C. Curtius, W. Pfleider, Biochemical and clinical aspects of pteridines 1982 Walter de Gruyter Berlin 81 102
33. M. Nomoto Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis Neurology 41 3 1991 457
34. M. Ott Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis Journal of Neurology 241 2 1993 108 114 (Pubitemid 23362659)
35. J. Peltola Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy Neurology 57 5 2001 895 896 (Pubitemid 32845516)
36. A. Pezzoli, and E. Pascali Bence Jones proteinuria in multiple sclerosis Clinical Chemistry 33 10 1987 1923 1924 (Pubitemid 19097579)
37. K. Rejdak Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis Multiple Sclerosis 16 9 2010 1066 1072
38. J.n. Rinker, K. Trinkaus, and A. Cross Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis Neurology 67 7 2006 1288 1290 (Pubitemid 44563847)
39. R. Rudick Multiple sclerosis: free light chains in cerebrospinal fluid Neurology 35 10 1985 1443 1449 (Pubitemid 15242418)
40. C.E. Shaw Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission Journal of Neurology 242 2 1995 53 58
41. K.J. Smith, and H. Lassmann The role of nitric oxide in multiple sclerosis Lancet Neurology 1 4 2002 232 241 (Pubitemid 37159185)
42. C. Tsai Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis Annals of Rheumatic Diseases 51 2 1992 168 172
43. G. Werner-Felmayer Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment Cancer Research 50 10 1990 2863 2867 (Pubitemid 20170730)
44. J.N. Whitaker Myelin basic protein in cerebrospinal fluid and other body fluids Multiple Sclerosis 4 1 1998 16 21 (Pubitemid 28077431)
45. J.N. Whitaker Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis Annals of Neurology 38 4 1995 625 632
46. J.N. Whitaker Urinary myelin basic protein-like material in patients with multiple sclerosis during interferon beta-1b treatment Archives of Neurology 56 6 1999 687 691 (Pubitemid 29266467)
47. G.J. Williams, and P.L. Witt Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX Journal of Interferon & Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 18 11 1998 967 975 (Pubitemid 28565800)